These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38871577)

  • 1. Size of Extranodal Extension in the Sentinel Lymph Node as a Predictor of Prognosis in Early-Stage Breast Cancer.
    Kustić D
    Clin Breast Cancer; 2024 Oct; 24(7):e560-e570. PubMed ID: 38871577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.
    Yang X; Ma X; Yang W; Shui R
    Sci Rep; 2020 Sep; 10(1):14684. PubMed ID: 32895434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracapsular extension in the positive sentinel lymph node: a marker of poor prognosis in cT1-2N0 breast cancer patients?
    Vane MLG; Willemsen MA; van Roozendaal LM; van Kuijk SMJ; Kooreman LFS; Siesling S; de Wilt HHW; Smidt ML
    Breast Cancer Res Treat; 2019 Apr; 174(3):711-718. PubMed ID: 30610488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis.
    Nottegar A; Veronese N; Senthil M; Roumen RM; Stubbs B; Choi AH; Verheuvel NC; Solmi M; Pea A; Capelli P; Fassan M; Sergi G; Manzato E; Maruzzo M; Bagante F; Koç M; Eryilmaz MA; Bria E; Carbognin L; Bonetti F; Barbareschi M; Luchini C
    Eur J Surg Oncol; 2016 Jul; 42(7):919-25. PubMed ID: 27005805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Nonsentinel Lymph Node Metastasis in Breast Cancer: A Multicenter Retrospective Study.
    Mikami Y; Yamada A; Suzuki C; Adachi S; Harada F; Yamamoto S; Shimada K; Sugae S; Narui K; Chishima T; Ishikawa T; Ichikawa Y; Endo I
    J Surg Res; 2021 Aug; 264():45-50. PubMed ID: 33752166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size of Extranodal Extension on Sentinel Lymph Node Dissection in the American College of Surgeons Oncology Group Z0011 Trial Era.
    Choi AH; Blount S; Perez MN; Chavez de Paz CE; Rodriguez SA; Surrusco M; Garberoglio CA; Lum SS; Senthil M
    JAMA Surg; 2015 Dec; 150(12):1141-8. PubMed ID: 26331347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients.
    Barrio AV; Downs-Canner S; Edelweiss M; Van Zee KJ; Cody HS; Gemignani ML; Pilewskie ML; Plitas G; El-Tamer M; Kirstein L; Capko D; Patil S; Morrow M
    Ann Surg Oncol; 2020 May; 27(5):1617-1624. PubMed ID: 31820212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
    Dong LF; Xu SY; Long JP; Wan F; Chen YD
    J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized prediction of non-sentinel lymph node metastasis in Chinese breast cancer patients with ≥ 3 positive sentinel lymph nodes based on machine-learning algorithms.
    Xie X; Fang Y; He L; Chen Z; Chen C; Zeng H; Chen B; Huang G; Guo C; Zhang Q; Wu J
    BMC Cancer; 2024 Sep; 24(1):1090. PubMed ID: 39223574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients.
    Canavese G; Tinterri C; Carli F; Garrone E; Spinaci S; Della Valle A; Barbieri E; Marrazzo E; Bruzzi P; Dozin B
    Eur J Surg Oncol; 2021 Aug; 47(8):1920-1927. PubMed ID: 33972144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Axillary Lymph Node Dissection be Omitted in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes Undergoing Mastectomy? A Systematic Review and Meta-Analysis of Real-World Evidence.
    Chen F; Li X; Lin X; Chen L; Lin Z; Wu H; Chen J
    World J Surg; 2023 Oct; 47(10):2446-2456. PubMed ID: 37249632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
    World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
    Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
    World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
    Cipolla C; Lupo S; Grassi N; Tutino G; Greco M; Eleonora D; Gebbia V; Valerio MR
    World J Surg Oncol; 2024 Apr; 22(1):100. PubMed ID: 38627759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases.
    Liu D; Chang L; Zhao X; Dai L; Cui H; Liu P; Zhai Z; Wu H; Ma X; Kang H
    Clin Breast Cancer; 2024 Jun; 24(4):e232-e243.e1. PubMed ID: 38368246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved detection of sentinel lymph node metastases allows reliable intraoperative identification of patients with extended axillary lymph node involvement in early breast cancer.
    Cotarelo CL; Zschöck-Manus A; Schmidt M; Schad A; Brochhausen C; Kirkpatrick CJ; Thaler S
    Clin Exp Metastasis; 2021 Feb; 38(1):61-72. PubMed ID: 33249518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
    Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
    Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.